FLYNN WINS GOLD AT CANCER AWARENESS AD AWARDS

We’re honored to announce that Flynn has been recognized with four gold award wins by the Cancer Awareness Advertising Awards (CAAA). These accolades celebrate creative excellence in healthcare marketing and reaffirms our commitment to crafting impactful, results-driven campaigns for brands that make a difference. “It’s always nice to have our hard work recognized, but it’s especially rewarding when it’s for projects that are helping address such important issues,” said agency president Katie Flynn. To win a CAAA gold award, work must be rated in the top 5% of entries. The 2024 ACTober Campaign, created for the Breast Cancer Coalition of Rochester (BCCR), earned two gold awards—one in the Total Advertising Campaigns category and another in Invitations. The latest work in Flynn’s 18 years of supporting BCCR’s mission, this campaign was designed to amplify awareness and increase participation in the annual ACTober fundraising event. For Reese Pharmaceutical, we took home two more golds for our work on ColoTest, an OTC brand dedicated to proactive colorectal cancer screening. Our ColoTest Social Media Campaign leveraged influencers to promote the newly launched product on Amazon and in Walmart stores nationwide, encouraging thousands to reach for ColoTest as an affordable, at-home screening option. Additionally, our ColoTest Video Ad was awarded gold in pharmaceutical TV/video advertising for its effective use of humor to start a conversation on screening avoidance and emphasize the importance of early detection. As an agency devoted to helping peace of mind brands perform better, we couldn’t be prouder to work alongside these cancer-fighting innovators in amplifying their message. Congratulations to all of the winners!